Loading clinical trials...
Loading clinical trials...
Ex-Vivo Expanded Allogeneic NK Cells for the Treatment of Solid Tumors of Pediatric Origin in Children and Young Adults
Conditions
Interventions
Cord Blood-derived Expanded Allogeneic Natural Killer Cells
Cyclophosphamide
+1 more
Locations
1
United States
M D Anderson Cancer Center
Houston, Texas, United States
Start Date
August 31, 2018
Primary Completion Date
February 26, 2026
Completion Date
February 26, 2026
Last Updated
March 20, 2026
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions